Patients with lung cancer who undergo surgery may potentially be cured. The resulting pathological staging gives an indication of 5-year survival and whether further treatment is recommended. To date, there is little research evidence regarding the way potential recurrence is communicated to patients by staff. This qualitative research used case studies to explore how information disclosure about possible recurrence was managed following lung cancer surgery and aimed to identify practice implications for clinical teams. Twelve patients were recruited and first postoperative surgical and subsequent oncology or follow-up consultations were recorded and transcribed. The perspective of the professionals involved in these clinics was ascertained through 30 in-depth interviews. Key themes in the data were identified using Framework Analysis. Recurrence risk was communicated to patients in a number of ways and levels of clarity and openness. Information provided by participants about early warning signs of recurrence varied. Findings indicate information provided was linked to the patient's prognosis and individual professionals' underlying communication approach. This study provides a unique insight into the views of lung cancer specialists regarding information disclosure and reveals the challenging nature and complexity of discussing recurrence following lung cancer surgery.
| INTRODUC TI ON
For patients who have a lung cancer that is amenable to surgery, having an operation is often seen as offering hope of a cure (Powell et al., 2015) . Recent international survival data indicate that 5-year survival for patients diagnosed with stage 1A lung cancer is 83%, while those diagnosed with a stage 3A cancer is 36% (Goldstraw et al., 2016) . Dealing with the possibility of cancer recurrence can be a day-to-day reality following treatment. How this reality is presented and discussed with patients and how they are supported following surgery is therefore of clinical importance.
Patients are offered surgery based on clinical stage of the lung cancer as well as overall fitness for surgery (National Collaborating Centre for Cancer, 2011). Patients who have surgery will have a definitive pathological staging as a result of analysis of the whole tumour and associated lymph node samples. Depending on this staging, patients may or may not be offered adjuvant treatment (Lim et al., 2010) . Meta-analyses of trials suggest that adjuvant chemotherapy can add around 4% improvement in absolute survival at 5 years (NSCLC Meta-analysis Collaborative Group, 2010) .
Following surgery and any adjuvant treatment, patients undergo a period of regular surveillance, typically over a period of 5 years.
There is lack of consensus on the most effective strategy and frequency for following up patients after surgery (Schmidt-Hansen, Baldwin, & Hasler, 2012) .
Patients generally consider the consultation following surgery to be very significant, representing a transition from one phase of their illness to another (Thorne & Stajduhar, 2012) . Such transitions create challenges, particularly regarding communicating potential risk of recurrence. Patients' preferences for information may vary; while some patients may find discussion of potential recurrence very challenging, or even irrelevant, some patients may also see it as an essential element of their information needs (Thorne & Stajduhar, 2012) .
Patients may use this information for various reasons, including
decision-making about further treatment, managing inherent uncertainty, or gaining a sense of control over their illness (Thorne, Hislop, Kuo, & Armstrong, 2006) . Current national and international guidelines on communication with patients suggest that patients should be empowered to take a shared role in decision-making about their care (National Cancer Taskforce, 2015) . However, British Thoracic Society guidelines urge caution when discussing definitive lung cancer prognosis and stage, due to the complexities and the potential for questions patients may not be emotionally equipped to deal with (British Thoracic Society, 2013) . Such divergences in guidelines can create a dilemma for practitioners.
Prognostic communication can have an impact on patients' sense of hope, both positively and negatively (Thorne, Oglov, Armstrong, & Hislop, 2007) . Two published reviews have explored prognostic communication in the wider cancer population (Hagerty, Butow, Ellis, Dimitry, & Tattersall, 2005; Johnson, Tod, Brummell, & Collins, 2015) . Much of the evidence on prognostic communication has focused on the breast cancer population. Clinicians may convey a sense of optimism for cure following surgery, despite the inherent risk of recurrence in the future (Step & Ray, 2011) . Furthermore, studies of postsurgical clinics suggested that goals for communication for both patients and clinicians were to facilitate hope . While clinicians gave some biomedical information in all consultations, hope was conveyed by positive evaluations of prognosis and further treatment. Where prognosis was poorer, clinicians focused more on factual biomedical information and positive evaluation was limited to factors such as surgical recovery (Mendick, Young, Holcombe, & Salmon, 2013) . In this way, hope was maintained by focusing on things other than long-term outcome.
Prognostic forecasting is inherently imprecise and uncertain.
Uncertainty also arises from the unpredictability of events for an individual patient. Individuals are prone to the "irreducible randomness and indeterminacy of natural events" (Han, Klein, & Arora, 2011; p832) . Managing and communicating uncertainty and risk can be challenging particularly in high stakes situations such as discussing recurrence risk after lung cancer surgery. Patients and professionals may have differing beliefs and understanding of these aspects of uncertainty. This can lead to very different attitudes when seeking or delivering information and the values attached to information based on statistics. Moreover, people can struggle to interpret statistical and population-based information in relation to individualised risk (Han et al., 2009; Powell et al., 2015) . Patients' subjective and emotional response to such information forms an intrinsic, and often dominant, part of patients' understanding of their situation (Zikmund-Fisher, Fagerlin, & Ubel, 2010) . Reyna (2012) describes two different mental representations of information presented to patients: "verbatim" and "gist" memory.
Gist memory focuses only on "fuzzy" detail and incorporates the subjective, emotional and psychological elements to create meaning. This works in parallel with the exact recall of verbatim memory.
People have a preference for encoding meaning at the gist level, but seek further detail if and when they consider it necessary (Reyna, Nelson, Han, & Pignone, 2015) . In the context of recurrence risk communication, it is likely that most patients will take away only a stripped-down impression of the information they are given.
However, when provided with numerical information, this can become particularly poignant and memorable for patients with cancer (Thorne et al., 2006) . Hence, statistical information presented during consultations may be recalled, but the context lost, leading to its implications being misconstrued.
Risk constructs can be presented in many different formats and range from implicit information to specific probabilities. Different formats will be better suited to conveying risk in different situations (Zikmund-Fisher, 2013) . The key distinctions lie between presenting the possibility that an event can happen, thus avoiding any precision, and giving probability estimations, detailing risk with more precision using numbers. Different levels of detail can be conveyed by placing these risks in context, by comparing with other situations and by presenting risk in relation to particular circumstances or choices.
Use of these different forms of risk communication tailors risk information to the level of specificity perceived as appropriate to the situation.
There is a paucity of research that examines the specific issues around communication and disclosure of possible recurrence for patients with lung cancer following surgery. This qualitative study aimed to partly address the evidence gap. It explored how information regarding possible recurrence was presented to patients and to gain insight into the way in which professionals manage this process in lung cancer clinical practice. The specific study objectives were to:
• Identify what information is given to patients regarding the longterm risk of lung cancer recurrence and/or survival after surgery
• Identify who gives this information.
• Explore the perceptions of different professionals regarding their role when discussing long-term risk of recurrence or survival after lung cancer surgery, including how they discriminate what information to disclose.
| ME THODS
Due to the exploratory nature of this research, it was important to gain an in-depth understanding of the way in which the subject of potential recurrence was managed, both by clinical teams and by patients and to examine underpinning attitudes and decisions.
Therefore, a qualitative research approach was taken (Ritchie, Lewis, McNaughton Nichols, & Ormston, 2014) . Case study methodology provided a mechanism to explore communication of recurrence over time and in clinic settings (Yin, 2014) . The postsurgical clinic is usually where the pathology results are first presented to the patient and was taken as the starting point of the study. Formal research ethics committee approval was gained (reference 15/LO/1183).
| Sample identification and recruitment method
Patients in the study were referred to two UK specialist thoracic surgery units from three, secondary care local lung cancer multidisciplinary teams (MDT). The study was conducted at the surgical units and at the local lung cancer hospitals. Figure 1 outlines the sample recruitment and data collection points in the study. Lung cancer nurse specialists (LCNS) based at the surgical centres, not otherwise involved in the study, identified potential patients while admitted for their surgery using predetermined inclusion/exclusion criteria (see Box 1). Purposive sampling was used to identify a wide range of patients with lung cancer in terms of age, stage and previous health experience, all undergoing potentially curative surgery, in line with the qualitative methods used. Written consent was obtained from patients and staff members involved in the study.
| Sample size
Twelve patients were recruited and formed the cases of the study.
A total of 20 health professionals were involved in the observed consultations with these patients and were recruited to the study.
They consisted of eight surgeons (four consultants, four registrars; three female, five male), four oncologists (all consultants; two male, two female), two chest physicians (both consultants, one male one female) and six LCNS (all female). If professionals saw more than one study patient, they were interviewed for each occasion. In total, 30 interviews were conducted across the 20 health professional participants (see Table 1 for details of the patient cases and the clinical staff involved).
If possible, recruitment should continue until data saturation has been achieved across all themes. In reality, this was a challenge due to the limited number of oncologists and professionals undertaking follow-up within each MDT pathway. However, the sample did contain a wide range of experience from both the patient and professional perspective (Baker & Edwards, 2012; Hennink, Kaiser, & Marconi, 2017) .
| Data collection
Observation of the first postoperative surgical and subsequent oncology or follow-up clinics was conducted. All patients attended a postoperative surgical clinic. Depending on the practice of the MDT, patients were seen either at the thoracic unit or at the local lung cancer hospital. Six patients were referred for consideration of adjuvant therapy and were seen locally in an oncology assessment clinic. Six other patients were referred for follow-up care with their local lung cancer team, and the first appointment was observed. The researcher (MJ) attended clinics as a participant observer with the patient. All Interviews lasted an average of 30 min (range 10-60 min).
| Data analysis
Clinic consultations and interviews were transcribed verbatim. Observational comments and field notes were added to the transcripts for inclusion in the analysis. Framework Analysis was used (Ritchie et al., 2014) . This involved a process of data familiarisation and development of an initial descriptive coding schema. Other members of the research team (AT, KC & SB) reviewed a number of these transcripts for coding consistency and validity of the themes.
An initial thematic framework was developed and an iterative process of applying the thematic framework, modifying and re-applying, facilitated its development to achieve the best possible fit with the data. The computer-assisted qualitative data analysis tool, NVivo 10 (QSR International Pty Ltd 2014), was used to index and sort the data by applying the final thematic framework (Silver & Lewins, 2014) . Matrices were constructed, allowing data to be visualised and analysed across and within cases (Ritchie et al., 2014) . Abstraction and interpretation of the data was facilitated by further analysis of groups of themes to identify linkages and patterns in the data.
| RE SULTS
Findings from clinic observations and professional interviews were combined and presented below. Three key themes were identified in this data. The first theme The range of the risk of recurrence information was divided into three subthemes; 
| Theme 1: The range of risk of recurrence information
Information presented regarding risk of lung cancer recurrence was given in a range of ways. Recurrence was discussed in relation to surgical findings, the potential role of adjuvant treatment, followup and surveillance and the recognition of early signs of recurrence.
Recurrence information was identified in the clinic transcripts and classified according to risk communication typologies closely based on those derived by Zikmund-Fisher (2013) . Examples taken from the clinic transcriptions for each typology are displayed in Table 2 .
The most explicit form of recurrence information was classified for each encounter and displayed in Table 3 . Cases were grouped into patients who were perceived by their surgeon to have a relatively "good prognosis" and patients with poorer prognosis, labelled "intermediate prognosis."
| Probability vs. possibility
Information was given in a range of ways, from using vague "implicit possibility" of recurrence, to giving "absolute probability" of recurrence or 5-year survival (See Table 2 for examples). One surgeon explained why he felt the survival statistics should be given routinely to patients, both as part of the surgical informed consent process, and as part of discussing the postoperative surgical outcome. 
[Surgeon 8 interview about Patient 11]
Other staff avoided giving numbers to patients unless patients "pushed" for this, or even avoided giving this sort of information at all.
Professionals gave a range of reasons during the interviews. Staff identified the problem of applying population statistics to individual patients.
[ Findings showed a wide range of strongly held views amongst clinical staff about offering assessments of prognosis to patients, which clearly influenced their practice.
| Effect of prognosis on risk of recurrence information
Where staff perceived a good prognosis patients were told about their good outcome from surgery.
[ 
So I think it's important that, if that's the case, that people go away feeling […] that it was all worthwhile […]. [Surgeon 4 interview about Patient 6]
Consultations differed as to how much this was explicitly flagged as good news, but patients were all told further treatment was not required. With the exception of Patient 11, who had already been given this information by the surgeon, patients went on to ask about cancer recurrence. However, not all patients received answers in terms of probability. Questions were mainly answered with "categorical possibility", such as "the risk is very low," or "it is unlikely." In contrast with the surgical clinics, in the follow-up clinics recurrence was frequently not discussed, or only implied in discussion about ongoing monitoring.
Despite wishing to convey certainty about the future to patients, staff were cautious about the concept of cure.
[…] people want to hear the cure word or use the cure word and we tread very carefully with that generally, or those of us that work in lung cancer for long enough. [LCNS 4 interview about Patient 6]
Staff talked about there being no guarantee of cure and this concept was used during clinics.
Surgeon 2: It is unlikely, but we cannot say one hundred per cent that you won't have a reoccurrence again. [Surgical clinic transcript Patient 4]
Patients with a less favourable prognosis were seen as more of a communication challenge. 
I think it becomes really difficult when you have any

I'm trying, when I'm explaining to him, to say that the glass is not half empty, but half full, you know what I mean? I'm saying to them yes, you are getting lung cancer. But. Always but. [Surgeon 3 interview about Patient 5]
Oncologists used discussion of possible cancer recurrence with all the patients referred to them as lead-in and context for introducing potential further treatment. However, discussions about recurrence were presented in terms of possibility rather than probability.
Oncologists sometimes used "comparative possibility" of recurrence to explain the rationale for chemotherapy.
Oncologist 1: […] when it has travelled to the lymph nodes, unfortunately it does mean that it is a bit more likely to flare up in the future. Because it has proven its ability to travel from one part to another […]. [Patient 8 oncology clinic transcript]
Oncologists discussed benefit of adjuvant treatment with the patients referred to them in terms of survival advantage or reducing recurrence with adjuvant therapy. Several patients were
given an "incremental probability," indicating the increase in 
| Uncertainty challenges
Patients with microscopically incomplete resections (denoted as R1) posed difficulties for clinicians. Predicting what impact this would have on the long-term outcome for patients was a challenge due to lack of evidence specific to this group.
[…] so if you look at the survival curves you only have T stages, N stages, and there's no survival curve for R. So I wouldn't know what her five-year survival is. [Surgeon 5 interview about Patient 9]
Conveying the uncertainty and complexity of this situation to patients also posed challenges. Another case that was challenging to provide a prognosis for was patient 6. She had been diagnosed with stage 3B cancer, initially received palliative chemotherapy, followed by maintenance therapy and was finally referred for surgery. The postsurgical pathology showed no active cancer. She asked about her risk of the cancer returning in the future, but staff were unable to offer clear estimations of the chance of cancer recurrence. 
So if it comes and goes away on its own, isn't cancer. [Patient 9 oncology clinic transcript]
Where they occurred, these explicit acknowledgements of possible cancer recurrence appear aimed at addressing the inherent uncertainty and fear of cancer recurrence.
Several professionals were concerned about the timing of discussions with patients about awareness of early signs of recurrence. Some were concerned about giving patients mixed messages during the surgical clinic by talking about good outcomes and discussing potential recurrence at the same time. Even later on during follow-up, staff were cautious about "frightening people" too early on after surgery with discussion about possible recurrence.
I just don't know that seeing somebody potentially eight weeks after an operation saying you might not be cured and it might come back, I don't feel is the right thing to do […]. [LCNS 2 interview about Patient 3]
Some professionals spoke about introducing the topic over several clinic visits in the context of the rationale behind surveillance.
However, none of the participants specified when the best time would be. Several professionals felt that it was essential to provide hope by delivering an optimistic message, even if the news was not particularly good.
| D ISCUSS I ON
These findings provide a unique insight into the views of professionals caring for patients with lung cancer regarding information disclosure. They reveal the challenging nature and complexity of discussing recurrence following lung cancer surgery. Clinicians in this study varied in how they discussed issues related to recurrence.
Styles of communication differed amongst patient professional pairs, and some differences were noted between the same professional when consulting with different patients.
A spectrum of approaches was adopted in relation to risk communication, and there were many similarities to the findings of Mendick et al. (2013) . Professionals were largely cautious about presenting information about recurrence beyond giving a possibility that it could happen. Good prognosis appeared to be conveyed to patients often without explicit discussion of recurrence, allowing patients to then ask for more information. This information was seen as hopeful and used to support patients' positive views of surgery and the future. Even for these patients, many professionals regarded specific numeric probabilities of recurrence as damaging to hope and not useful to individual patients. This indicates the inherent uncertainty in such information and mirrors some of the findings of Thorne et al. (2006) . One explanation for this observed difference in whether patients ask further questions about their prognosis is that patients using gist-level information, including tone and body language, rather than the verbatim account, to make an assessment of their outcome (Reyna, 2012) . The manner that hope was conveyed to patients with a good prognosis, rather than explicit facts, may determine whether patients felt safe to ask further questions, in the expectation of receiving further information likely to support hope. Other patients, although not explicitly told they had a poorer prognosis, may have taken the gist of the consultation and have realised that asking further information would not support hope.
Information about signs and symptoms of recurrence and what to do about these were not consistently discussed with study patients following surgery, even when not having ongoing treatment.
The National Cancer Survivorship Initiative advocates giving information on symptoms that might indicate recurrence or progression of disease at the end of primary treatment (NCSI, 2014).
The current study indicates that barriers may exist to implementing this with postsurgical lung cancer patients. This may in part be due to professionals' desire to support patient hope (Thorne & Stajduhar, 2012) . The lack of consensus on optimal follow-up programmes (National Collaborating Centre for Cancer, 2011) could also reduce clinicians' confidence in postoperative follow-up and so the whole approach to detecting early recurrence. There are limited options for treating patients with relapsed lung cancer and this may also influence attitudes to long-term surveillance and the value of increasing patient anxiety levels by discussing possible signs of recurrence. However, with recent developments in radiation and systemic therapy, as well as possible further resection, this situation may well begin to change (Goldstraw et al., 2011) .
Choices that staff make about information for patients with postsurgical lung cancer are complex. These findings suggest that both clinicians and patients appeared to be managing uncertainty as a dynamic process during these information exchanges.
The findings are supported by previous literature and suggest a tacit agreement exists between professionals and patients with lung cancer to manage uncertainty in a way that promotes hope (Johnson et al., 2015) . Professionals talked about presenting information honestly and realistically, not damaging patients' fragile hope by giving too much or the wrong type information.
This was a priority for most clinicians, mirroring the findings of . Some staff participants took either an optimistic or realistic approach to information giving. Most staff, however, emphasised the need to maintain a careful balance in their communication to meet the patient's individual information needs. Judging this balance would appear to require a skilled clinical relationship that takes as its starting point the expertise of the clinician and the inevitable vulnerability of the patient .
| Study strengths and limitations
This is the first in-depth exploration of the discussion of recurrence risk following lung cancer surgery. Examination of the multidisciplinary approach to these discussions, as patients move between teams, allows an understanding of how this disclosure process happens over time. Triangulation of the data between clinical observation of what was said, together with the professional's rationale for the information that was given, allows a greater depth of understanding of the decision-making processes involved in selecting the type and format of information. As a qualitative case study, the sample was robust and was based on a good range of patients. The different cancer stages within this study population exposed the difference in approach to information giving used by staff, when confronted with patients with divergent prognoses. 
| CON CLUS ION
This study enhances the understanding of the challenges in communicating risk of recurrence following lung cancer surgery. It highlights how complex it is for clinicians to balance hope and uncertainty, while conveying the information that a patient may need.
Awareness of the strategies that clinical staff employ, often unconsciously, when talking with patients about difficult subjects, could help staff tailor their communication to individual patient information needs and coping style. It is important to recognise how significant and meaningful these consultations are for patients, and how subtle and complex the communication within them really is. Staff providing this care need to have the skills and support necessary to ensure this care is provide as well as possible.
